13F

Stock

CNS Pharmaceuticals, Inc.

CNSP · held by 10 managers

Reported value

$652.4K

Holders

10

+1 new · −1 exited

Holders’ est. mark

−$15

Price effect on 1 books still in the name

Largest holder

$256.3K

Stonepine Capital Management, LLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
Stonepine Capital Management, LLC48.8K$256.3KHeld
Ikarian Capital, LLC45.8K$240.6KHeld
DRW Securities, LLC15.4K$81KHeld
BOOTHBAY FUND MANAGEMENT, LLC13.5K$71KHeld
UBS Group AG611$3.21KHeld
Sound Income Strategies, LLC16$113Held
BARRETT & COMPANY, INC.8$42Held
BANK OF AMERICA CORP /DE/4$21−$15Cut−$15
MAI Capital Management3$16Held
DANSKE BANK A/S1$5New

Who left

Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.